bristol-myers squibb co. jumped 5.4 percent in new york after goldman sachs group inc. raised its rating on the drugmaker to 「buy」 from 「neutral.

纽约股市方面，高盛公司把百时美施贵宝公司（bristol-myerssquibb）的评级从“中性」调高到「买入」后，这家制药商的股价上涨5.4%。

and the new japan has some old members: ono pharmaceutical, a drugmaker with margins of 37% between 2000 and 2009, was founded in 1717.

新日本成员中叶有些老企业：制造企业--小野药业，成立于1717，2000-2009年的利润率高达37%。

the u.s.food and drug administration sent a warning letter to the drugmaker at the time, saying it had waited more than a year to notify regulators after getting complaints of customers becoming sick.

美国食品药品监督局那时发了一封警告给制药商并称其在收到消费者致病投诉一年多才上报监管部门。

the drugmaker did not change its full-year 2010 earnings outlook, but said it now expects revenue growth in the low- to mid-single digits, down from a previous estimate for mid-single digit growth.

该制药商并没有改变其全年盈利预期到2010年，但礼来公司表示，预计收入的增长率为较低的中等水平个位数，低于此前预期。

a year-over-year change in the number of approvals could result from numerous factors, including increased drugmaker productivity in the face of a tougher fda, or vice versa.

在申请数量上的年基变化可能是由多种因素造成的，包括在面对强有力的fda时企业的生产能力增加，或者反之亦然。

the right alzheimer's drug could earn a drugmaker a lot of money.

一个有效的药物能让开发商挣不少钱。

the 30 largest swiss companies reported earnings growth of 38 percent during the past four years, buoyed by exports from watchmaker swatch group ag, nestle and drugmaker novartis ag.

据报道，过去四年中，由于手表制造商斯沃琪集团，雀巢以及制药公司诺华股份有限公司的拉动，瑞士前30强公司收益增长率高达38%。

the 30 largest swiss companies reported earnings growth of 38 percent during the past four years, buoyed by exports from watchmaker swatch group ag, nestle and drugmaker novartis ag.

据报道，过去四年中，由于手表制造商斯沃琪集团，雀巢以及制药公司诺华股份有限公司的拉动，瑞士前

the giant drugmaker has taken a hit from the stronger dollar, a particular concern for the company because 54% of its sales come from foreign markets.

特别令人关注的是这家制药巨头受到美元走强的打击，因为该公司54%的销售额来自海外市场。

the drugmaker added that the ems impurities were caused by the manufacturing process of the drug, which is known generically as nelfinavir mesylate.

药品制造商补充说，ems杂质在药物生产过程中产生，通常认为是甲磺酸奈非那韦。

the drugmaker consequently lowered its outlook for 2010 revenue growth and its shares fell nearly 3 percent.

这家制药公司因此调低了2010年预计收入增长率，股票下跌近3个百分点。

the new jersey-based drugmaker was sued by tens of thousands of former vioxx users who claimed to have been injured by the arthritis medicine.

以新泽西为生产基地的默克公司被数以千计万络使用者控告，这些使用者声称他们在关节炎治疗中受到伤害。

ipsen sa fell 3 percent to 24.30 euros after the drugmaker was downgraded to 「underperform」 from 「neutral」 at bofa merrill lynch global research.

制药商法国易普森公司（ipsen）股价下跌3%，至24.30欧元，美国银行美林全球研究中心把该公司股票评级从中性下调为减持。

roche gained 1.4 percent to 144.5 francs after the drugmaker said it will cut 4,800 jobs as part of a cost- reduction program aimed at saving 2.4 billion francs ($2.4 billion) annually.

瑞士罗氏制药公司股价上涨1.4%，至144.5瑞士法郎，该公司公布了一项削减成本的计划，表示将削减4800个工作岗位，旨在每年节省24亿瑞士法郎（约合24亿美元）的运营成本。